Too complex for the Canva crowd, and too lightweight for Adobe users, Apple's Creator Studio subscription straddles an ...
insitro has acquired Israeli AI therapeutics company CombinAbleAI and launched its TherML platform, creating an end-to-end, ...
The NEO-CYT study, sponsored by Fondazione Melanoma Onlus, will be evaluating MDNA11 in front-line therapy for resectable ...
4h
Medicenna Therapeutics Corp.: Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, ...
China may emerge from the war in Ukraine in a stronger strategic position than any of the belligerents, despite never ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback